(Q42270440)

19 October 2017

Improved metabolic profile after switch to darunavir/ritonavir in HIV positive patients previously on protease inhibitor therapy (English)

1 reference

19 October 2017

1 reference

Claudio Ucciferri

1

1 reference

19 October 2017

Katia Falasca

2

1 reference

19 October 2017

Francesca Vignale

3

1 reference

19 October 2017

Marta Di Nicola

4

1 reference

19 October 2017

Eligio Pizzigallo

5

1 reference

19 October 2017

Jacopo Vecchiet

6

1 reference

19 October 2017

1 May 2013

1 reference

Journal of Medical Virology

19 October 2017

1 reference

19 October 2017

85

1 reference

19 October 2017

5

1 reference

19 October 2017

755-759

1 reference

Cystatin C--a marker of peripheral atherosclerotic disease?

19 October 2017

1 reference

Follow-up of a multi-drug resistant HIV-1 infected patient successfully treated with darunavir and etravirine

21 January 2018

1 reference

Microalbuminuria associated with indicators of inflammatory activity in an HIV-positive population

21 January 2018

1 reference

Dyslipidaemia associated with antiretroviral therapy in HIV-infected patients

21 January 2018

1 reference

Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials

21 January 2018

1 reference

Efficacy of once-daily darunavir/ritonavir 800/100 mg in HIV-infected, treatment-experienced patients with no baseline resistance-associated mutations to darunavir

21 January 2018

1 reference

The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial

21 January 2018

1 reference

Cystatin C, adipokines and cardiovascular risk in HIV infected patients

21 January 2018

1 reference

Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection

21 January 2018

1 reference

Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection

21 January 2018

1 reference

Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV-1-infected patients at week 48.

21 January 2018

1 reference

Effect of simplification from protease inhibitors to boosted atazanavir-based regimens in real-life conditions

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JMV.23543

1 reference

19 October 2017

1 reference